Shield Therapeutics PLC (GB:STX)
LSE:STX
Want to see GB:STX full AI Analyst Report?
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | £ 50.74M | £ 25.18M | £ 13.09M | £ 5.50M | £ 1.52M |
| Gross Profit | £ 22.38M | £ 10.57M | £ 4.03M | £ 2.00M | £ 539.00K |
| Operating Income | £ -10.30M | £ -17.98M | £ -31.33M | £ -26.39M | £ -20.41M |
| EBITDA | £ -10.30M | £ -16.58M | £ -30.29M | £ -46.07M | £ -17.69M |
| Net Income | £ -18.03M | £ -21.27M | £ -33.29M | £ -40.44M | £ -19.34M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | £ 11.63M | £ 5.61M | £ 13.95M | £ 2.82M | £ 12.12M |
| Total Assets | £ 65.24M | £ 45.90M | £ 48.80M | £ 22.07M | £ 44.41M |
| Total Debt | £ 30.15M | £ 21.06M | £ 20.41M | £ 6.10M | £ 156.00K |
| Net Debt | £ 18.52M | £ 15.45M | £ 6.46M | £ 3.28M | £ -11.96M |
| Total Liabilities | £ 80.32M | £ 46.95M | £ 26.49M | £ 16.65M | £ 3.38M |
| Stockholders' Equity | £ -15.08M | £ -1.05M | £ 11.79M | £ 5.43M | £ 40.69M |
| Cash Flow | |||||
| Free Cash Flow | £ -8.83M | £ -7.03M | £ -40.07M | £ -20.14M | £ -18.80M |
| Operating Cash Flow | £ -8.81M | £ -7.01M | £ -37.13M | £ -18.25M | £ -16.74M |
| Investing Cash Flow | £ -306.29K | £ -1.89M | £ -2.43M | £ -1.70M | £ -2.05M |
| Financing Cash Flow | £ 13.75M | £ 4.21M | £ 49.66M | £ 7.71M | £ 27.58M |